Jeff Yass’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-24,100
| Closed | -$433K | – | 10824 |
|
|
2017
Q4 | $433K | Sell |
24,100
-1,400
| -5% | -$17.2K | ﹤0.01% | 6905 |
|
|
2017
Q3 | $301K | Sell |
25,500
-400
| -2% | -$4.49K | ﹤0.01% | 7392 |
|
|
2017
Q2 | $272K | Sell |
25,900
-18,600
| -42% | -$190K | ﹤0.01% | 7753 |
|
|
2017
Q1 | $490K | Sell |
44,500
-21,300
| -32% | -$247K | ﹤0.01% | 6524 |
|
|
2016
Q4 | $892K | Buy |
65,800
+32,200
| +96% | +$449K | ﹤0.01% | 5776 |
|
|
2016
Q3 | $414K | Buy |
33,600
+2,700
| +9% | +$31.8K | ﹤0.01% | 6403 |
|
|
2016
Q2 | $339K | Sell |
30,900
-8,800
| -22% | -$98.5K | ﹤0.01% | 6758 |
|
|
2016
Q1 | $434K | Buy |
39,700
+5,200
| +15% | +$65.7K | ﹤0.01% | 6654 |
|
|
2015
Q4 | $597K | Buy |
34,500
+5,700
| +20% | +$102K | ﹤0.01% | 6429 |
|
|
2015
Q3 | $572K | Sell |
28,800
-13,100
| -31% | -$300K | ﹤0.01% | 6864 |
|
|
2015
Q2 | $688K | Sell |
41,900
-7,000
| -14% | -$121K | ﹤0.01% | 6989 |
|
|
2015
Q1 | $761K | Buy |
48,900
+31,400
| +179% | +$487K | ﹤0.01% | 6301 |
|
|
2014
Q4 | $250K | Buy |
+17,500
| New | +$185K | ﹤0.01% | 8440 |
|
|
2014
Q3 | – | Sell |
-37,900
| Closed | -$262K | – | 10291 |
|
|
2014
Q2 | $262K | Sell |
37,900
-58,700
| -61% | -$415K | ﹤0.01% | 8613 |
|
|
2014
Q1 | $691K | Buy |
96,600
+86,500
| +856% | +$740K | ﹤0.01% | 6179 |
|
|
2013
Q4 | $95K | Sell |
10,100
-38,700
| -79% | -$276K | ﹤0.01% | 8653 |
|
|
2013
Q3 | $305K | Buy |
+48,800
| New | +$305K | ﹤0.01% | 7173 |
|
Other funds holding SCMP
Jeff Yass's SCMP Position: Q1 2018 in Review
Jeff Yass sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 176,051 shares — an estimated $3.16M sold.
Jeff Yass first reported a position in SCMP in Q4 2014 and held it in 11 quarters. The position peaked at $4.26M in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.
- Jeff Yass reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
- Jeff Yass sold 176,051 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $3.16M.
- Jeff Yass first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2014 and held it in 11 quarters.
- Jeff Yass's Sucampo Pharmaceuticals, Inc. position peaked at $4.26M in Q3 2015.
- 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.
Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.